These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 625290)

  • 1. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
    Mittag TW; Tormay A; Massa T
    Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
    [No Abstract]   [Full Text] [Related]  

  • 2. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
    Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
    No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle.
    Drachman DB; Kao L; Angus CW; Murphy A
    Trans Am Neurol Assoc; 1977; 102():96-100. PubMed ID: 616125
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors.
    Molenaar PC; Polak RL; Miledi R; Alema S; Vincent A; Newsom-Davis J
    Prog Brain Res; 1979; 49():449-58. PubMed ID: 515442
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
    Vincent A; Newsom-Davis J
    Adv Cytopharmacol; 1979; 3():269-78. PubMed ID: 474297
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
    Drachman DB; Pestronk A; Stanley EF
    Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyositis: reduction of acetylcholine receptors in skeletal muscle.
    Pestronk A; Drachman DB
    Muscle Nerve; 1985; 8(3):233-9. PubMed ID: 4058467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to acetylcholine receptors increases the turnover of acetylcholine receptor: clinical relevance and mechanism of action.
    Clementi F; Conti Tronconi B; Fumagalli G; Pelloja F; Sher E; Sinigaglia F; Villa A
    Ann Ist Super Sanita; 1982; 18(1):69-74. PubMed ID: 7171175
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B; Morel E; Bach JF
    C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acetylcholine receptors and myasthenia gravis].
    Yagi K; Uono M
    Nihon Rinsho; 1979; 37(8):3115-24. PubMed ID: 390183
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
    Lindstrom J
    Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conceptual aspects of myasthenia gravis].
    Ledro Molina D; Avilés Mejías S; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.